{"meta":{"query_hash":"1120bd5997d2","filters":{"venue":"OphthaTherapy Therapies in Ophthalmology"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1120bd5997d2","api":"https://metacan.xera.ac/api/v1/cohort?venue=OphthaTherapy+Therapies+in+Ophthalmology"},"results":[{"id":"W3023597032","doi":"10.24292/01.ot.310320.05","title":"Potencjalne zastosowanie agonistów dopaminergicznych D2 w leczeniu VEGF-zależnych chorób oczu","year":2020,"lang":"pl","type":"article","venue":"OphthaTherapy Therapies in Ophthalmology","topic":"Neurological Complications and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"","keywords":"Agonist; Medicine; Nuclear chemistry; Chemistry; Chromatography; Internal medicine; Receptor","score_opus":0.0700454987480153,"score_gpt":0.31805625460356374,"score_spread":0.24801075585554844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023597032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90587234,0.02926449,0.00011818237,0.04167587,0.0015244663,0.0018225398,0.00011608204,0.00022904956,0.01937695],"genre_scores_gemma":[0.9810631,0.0043846383,0.0012439606,0.00665827,0.0012228887,0.00030657687,0.00012885872,0.00027275263,0.0047189277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915534,0.0012540091,0.0018979193,0.0024456866,0.0008452216,0.0020037224],"domain_scores_gemma":[0.9955262,0.00088120514,0.00062606327,0.0018005782,0.00029387933,0.0008720821],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00078250386,0.0014395728,0.0025449507,0.0005170805,0.00046329538,0.00018554696,0.0017581003,0.0011683491,0.013628701],"category_scores_gemma":[0.00029986957,0.0012939658,0.0007167574,0.0019470508,0.0012537438,0.00027641671,0.000398222,0.0022406606,0.0011426725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02435745,0.017211497,0.40746254,0.0020254776,0.005203665,0.075918384,0.030891305,0.00074216543,0.34212607,0.021560075,0.01136063,0.06114074],"study_design_scores_gemma":[0.030805027,0.051426027,0.61578244,0.0006953938,0.0007481442,0.061351232,0.004335492,0.0034620545,0.0040542134,0.016325751,0.20443012,0.0065841023],"about_ca_topic_score_codex":0.00015428274,"about_ca_topic_score_gemma":0.0000029639418,"teacher_disagreement_score":0.33807185,"about_ca_system_score_codex":0.00022742504,"about_ca_system_score_gemma":0.0003650196,"threshold_uncertainty_score":0.99983543},"labels":[],"label_agreement":null}]}